Predictive Oncology Stock Price on December 31, 2023
| POAI Stock | USD 1.26 0.13 9.35% |
If you're considering investing in Predictive Stock, it is important to understand the factors that can impact its price. As of today, the current price of Predictive Oncology stands at 1.26, as last reported on the 3rd of March, with the highest price reaching 1.47 and the lowest price hitting 1.24 during the day. Predictive Oncology is abnormally volatile given 3 months investment horizon. Predictive Oncology maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.28% are justified by taking the suggested risk. Use Predictive Oncology Semi Deviation of 7.07, risk adjusted performance of 0.0926, and Coefficient Of Variation of 897.08 to evaluate company specific risk that cannot be diversified away.
Predictive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Predictive |
Sharpe Ratio = 0.1115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | POAI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.46 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.28 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Predictive Oncology is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predictive Oncology by adding it to a well-diversified portfolio.
Predictive Oncology Valuation on December 31, 2023
It is possible to determine the worth of Predictive Oncology on a given historical date. On December 31, 2023 Predictive was worth 3.32 at the beginning of the trading date compared to the closed value of 3.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Predictive Oncology stock. Still, in general, we apply an absolute valuation method to find Predictive Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Predictive Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Predictive Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 3.32 | 3.40 | 3.18 | 3.39 | 31,900 | |
12/29/2023 | 3.32 | 3.43 | 3.26 | 3.29 | 19,100 |
| 3.25 | 3.54 | 3.25 | 3.53 | 23,900 |
| Backtest Predictive Oncology | | | Predictive Oncology History | | | Predictive Oncology Valuation | Previous | Next |
Predictive Oncology Trading Date Momentum on December 31, 2023
| On January 02 2024 Predictive Oncology was traded for 3.53 at the closing time. The top price for the day was 3.54 and the lowest listed price was 3.25 . The trading volume for the day was 23.9 K. The trading history from January 2, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 7.29% . The trading delta at closing time against the current closing price is 3.95% . |
Predictive Oncology Fundamentals Correlations and Trends
By evaluating Predictive Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Predictive Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Predictive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Predictive Oncology Stock history
Predictive Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Predictive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Predictive Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Predictive Oncology stock prices may prove useful in developing a viable investing in Predictive Oncology
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence primarily in the United States. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. Predictive Oncology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Predictive Oncology Stock Technical Analysis
Predictive Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Predictive Oncology Period Price Range
Low | March 3, 2025
| High |
0.00 | 0.00 |
Predictive Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Predictive Oncology March 3, 2025 Market Strength
Market strength indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By undertsting and applying Predictive Oncology stock market strength indicators, traders can identify Predictive Oncology entry and exit signals to maximize returns
Predictive Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Predictive Oncology's price direction in advance. Along with the technical and fundamental analysis of Predictive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Predictive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0926 | |||
| Jensen Alpha | 1.45 | |||
| Total Risk Alpha | 2.2 | |||
| Sortino Ratio | 0.1636 | |||
| Treynor Ratio | 0.4298 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |